Additionally, the IC50 values for NSCLC cells treated with cisplatin increased upon ZNF131 overexpression, as opposed to overexpression of ZNF131-∆ZF and ZNF131-∆BTB (Figure 7E). This evidence concerns the gene ZBTB35 and non-small cell lung carcinoma.